• 1
    Mito M, Kusano M, Sawa M. Hepatocyte transplantation for hepatic failure. Transplant Rev 1993; 7: 3543.
  • 2
    Mito M, Ebata H, Kusano M, Onishi T, Saito T, Sakamoto S. Morphology and function of isolated hepatocytes transplanted into rat spleen. Transplantation 1979; 28: 499505.
  • 3
    Makino S, Katagiri K. Osteogenic disorder rat. Exp Anim 1980; 29: 374377.
  • 4
    Onodera K, Kasai S, Kato K, Nakazawa F, Mito M. Long-term effect of intrasplenic hepatocyte transplantation in congenitally ascorbic acid biosynthetic enzyme-deficient rats. Cell Transplant 1995; 4 (suppl)l: 4143.
  • 5
    LaBrecque DR, Bachur NR. Hepatic stimulator substance: physiological characteristics and specificity. Am J Physiol 1982; 242: 281288.
  • 6
    Jiang B, Kasai S, Sawa M, Hirai S, Yamamoto T, Ebata H, Mito M. Beneficial effect of hepatic stimulatory substances on the survival of intrasplenically transplanted hepatocytes. Cell Transplant 1993; 2: 325329.
  • 7
    Jiang B, Sawa M, Yamamoto T, Kasai S. Enhancement of proliferation of intrasplenically transplanted hepatocytes in cirrhotic rats by hepatic stimulatory substance. Transplantation 1997; 63: 131135.
  • 8
    Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265.
  • 9
    Berry MN, Friend DS. High yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structure study. J Cell Biol 1969; 43: 506520.
  • 10
    Gupta S, Yemeni PR, Veneru RP, Lee CD, Yellin EL, Bhargava KK. Studies on the safety of intrasplenic hepatocyte transplantation: relevance to ex vivo gene therapy and liver repopulation in acute hepatic failure. Hum Gene Ther 1993; 4: 249257.
  • 11
    Rozga J, Holzman M, Moscioni AD, Fujioka H, Morsiani E, Demetriou AA. Repeated intraportal hepatocyte transplantation in analbuminemic rats. Cell Transplant 1995; 4: 2: 237243.
  • 12
    Ogawa Y, Kishigami M. Study regarding to the measurement method for vitamin C in tissue. Annu Rep Shionogi Res Lab 1957; 7: 637647 [in Japanese].
  • 13
    Vroemen JPAM, Buurman WA, Heirwegh KPM, Linden CJVD, Kootstra G. Hepatocyte transplantation for enzyme deficiency disease in congenic rats. Transplantation 1986; 42: 130135.
  • 14
    Nozawa M, Otsu I, Ikebukuro H, Makino S. Effect of fetal liver transplantation in rats with congenital metabolic disease. Transplant Proc 1991; 23: 1: 889891.
  • 15
    Nordlinger B, Wang SR, Bouma ME, Verthier N, Hillan K, Delelo R, Infante R. Can hepatocytes proliferate when transplanted into the spleen? Eur Surg Res 1987; 19: 381387.
  • 16
    Henne-Bruns D, Anbrass FO, Schmiegelow P, Hoehen M, Paul D, Kremer B. Intrasplenic hepatocyte transplantation: evaluation of DNA synthesis and proliferation in auxiliary transplanted cells. Res Exp Med 1989; 189: 295298.
  • 17
    Hillan KJ, Burt AD, George WD, Macsween NM, Griffith MR, Bradley JA. Intrasplenic hepatocyte transplantation in rats with experimental liver injury: morphological and morphometric studies. J Pathol 1989; 159: 6773.
  • 18
    Finkelstein SD, Lee G, Tatematsu M, Makowka L, Farber E. An experimental method for rapid growth of liver in spleen: the survival and proliferation of chemically induced preneoplastic hepatocytes in spleen. Am J Pathol 1983; 110: 119.
  • 19
    Moscioni AD, Rozga J, Chen S, Nairn A, Scott HS, Demetriou AA. Long-term correction of albumin levels in the nagase analbuminemic rat: repopulation of the liver by transplanted normal hepatocytes under a regeneration response. Cell Transplant 1996; 5: 4: 499503.
  • 20
    Francavilla A, Dileo A, Polimeno L, Cavaler J, Pellicci R, Makowka L, Starzl TE, et al. The effect of hepatic stimulatory substance, isolated from regenerating hepatic cytosol, 50,000 and 300,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with D-galactosamine. Hepatology 1986; 6: 13461351.
  • 21
    LaBrecque DR. Hepatic stimulator substance: discovery, characteristics and mechanism of action. Dig Dis Sci 1991; 36: 669673.
  • 22
    LaBrecque DR, Pesch LA. Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver. J Physiol 1975; 248: 273284.
  • 23
    Van Hoorn-Hickman R, Kahn D, Green J, MacLeod HA, Terblanche J. Is there a regeneration stimulator substance in the effluent from perfused partially hepatectomized livers? Hepatology 1981; 1: 287293.
  • 24
    Schwarz LC, Makowka L, Falk JA, Falk R. The characterization and partial purification of hepatocyte proliferation factor. Ann Surg 1985; 202: 296302.
  • 25
    Mori S, Ito N. Pathological studies on urinary bladder carcinogenesis in male ODS-od/od rats unable to synthesize L-ascorbic acid. Medical Journal of Nagoya City University 1991; 42: 447472 [in Japanese].
  • 26
    Michalopoulos GK. Liver regeneration: molecular mechanisms of growth control. J Fed Am Soc Exp Biochem 1990; 4: 176187.
  • 27
    Stolz DB, Michalopoulos GK. Comparative effects of hepatocyte growth factor and epidermal growth factor on motility, morphology, mitogenesis, and signal transduction of primary rat hepatocytes. J Cell Biochem 1994; 55: 445464.
  • 28
    Kato K, Onodera K, Sawa M, Imai M, Kawahara T, Kasai S, Mito M. Effect of hepatocyte growth factor on the proliferation on intrasplenically transplanted hepatocytes in rats. Biochem Biophys Res Commun 1996; 222: 101106.
  • 29
    Francavilla A, Azzarone A, Carrieri G, Scotti-Foglieni C, Zeng QH, Cillo U, Starzl TE, et al. Effect on the canine Eck fistula liver of intraportal TGF-β alone or with hepatic growth factors. Hepatology 1992; 16: 12671270.
  • 30
    Hagiya M, Francavilla A, Polimeno L, Ihara I, Sakai H, Seki T, Starzl TE, et al. Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A 1994; 91: 81428146.
  • 31
    He F, Wu C, Tu Q, Xing G. Human hepatic stimulator substance: a product of gene expression of human fetal liver tissue. Hepatology 1993; 17: 225229.
  • 32
    Grossman M, Rader DJ, Mullur DWM, Kolansky DM, Kozarsky K, Clark III BJ, Wilson JM, et al. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolemia. Nat Med 1995; 1: 11481154.